http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107043371-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
filingDate | 2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107043371-B |
titleOfInvention | β2-AR agonistic and anti-inflammatory bifunctional alkaloids and their applications |
abstract | The invention discloses an alkaloid represented by formula I or formula II, its analog, isomer, racemate or derivative; The above-mentioned compounds are obtained from Portulaca oleracea for the first time in the present invention, and research finds that the above-mentioned compounds have β2 - AR agonistic and anti-inflammatory bifunctional activities, and provide useful compounds for the treatment of respiratory diseases such as asthma and related inflammatory diseases. . |
priorityDate | 2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 156.